136 related articles for article (PubMed ID: 35117275)
1. TM9SF4 expression in tumor tissues: a novel diagnostic biomarker for gastrointestinal tumors.
Guazzi P; Zocco D; Isajevs S; Zarovni N; Bianciardi L; Toots M; Sivins A; Leja M; Chiesi A; Lozupone F
Transl Cancer Res; 2020 Nov; 9(11):6652-6659. PubMed ID: 35117275
[TBL] [Abstract][Full Text] [Related]
2. TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cells.
Lozupone F; Borghi M; Marzoli F; Azzarito T; Matarrese P; Iessi E; Venturi G; Meschini S; Canitano A; Bona R; Cara A; Fais S
Oncogene; 2015 Oct; 34(40):5163-74. PubMed ID: 25659576
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients.
Ning S; Wei W; Li J; Hou B; Zhong J; Xie Y; Liu H; Mo X; Chen J; Zhang L
J Cancer; 2018; 9(3):494-501. PubMed ID: 29483954
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of TM9SF4 boosts ER stress to trigger cell death of chemoresistant breast cancer cells.
Zhu Y; Xie M; Meng Z; Leung LK; Chan FL; Hu X; Chi K; Liu C; Yao X
Oncogene; 2019 Jul; 38(29):5778-5791. PubMed ID: 31249383
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
[TBL] [Abstract][Full Text] [Related]
6. Golgi Phosphoprotein 3 Represents a Novel Tumor Marker for Gastric and Colorectal Cancers.
Wang CX; Zhuang HB; Shi ZS; Qiu CZ; Chen ZX; Tang LF
Dis Markers; 2021; 2021():8880282. PubMed ID: 33680216
[TBL] [Abstract][Full Text] [Related]
7. Role of SPP1 in the diagnosis of gastrointestinal cancer.
Jiang N; Jin L; Li S
Oncol Lett; 2023 Sep; 26(3):411. PubMed ID: 37614657
[TBL] [Abstract][Full Text] [Related]
8. TNM staging for GIT cancers is correlated with the level of MMPs and TGF-β1.
El-Ashmawy NE; Khedr NF; Mansour MG; Al-Ashmawy GM
Clin Exp Med; 2020 Nov; 20(4):545-555. PubMed ID: 32772210
[TBL] [Abstract][Full Text] [Related]
9. Human TM9SF4 Is a New Gene Down-Regulated by Hypoxia and Involved in Cell Adhesion of Leukemic Cells.
Paolillo R; Spinello I; Quaranta MT; Pasquini L; Pelosi E; Lo Coco F; Testa U; Labbaye C
PLoS One; 2015; 10(5):e0126968. PubMed ID: 25961573
[TBL] [Abstract][Full Text] [Related]
10. Comparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancer.
Park WC; Kim HR; Kang DB; Ryu JS; Choi KH; Lee GO; Yun KJ; Kim KY; Park R; Yoon KH; Cho JH; Lee YJ; Chae SC; Park MC; Park DS
BMC Cancer; 2016 Jun; 16():358. PubMed ID: 27282379
[TBL] [Abstract][Full Text] [Related]
11. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
12. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
[TBL] [Abstract][Full Text] [Related]
13. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
14. Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors.
Xu L; Cai Y; Chen X; Zhu Y; Cai J
BMC Cancer; 2021 Sep; 21(1):989. PubMed ID: 34479528
[TBL] [Abstract][Full Text] [Related]
15. PYGO2 as an independent diagnostic marker expressed in a majority of colorectal cancers.
Soleymani S; Khales SA; Jafarian AH; Kalat HR; Forghanifard MM
J Histotechnol; 2019 Sep; 42(3):98-103. PubMed ID: 31492088
[TBL] [Abstract][Full Text] [Related]
16. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis.
Wu W; Juan WC; Liang CR; Yeoh KG; So J; Chung MC
Proteomics Clin Appl; 2012 Apr; 6(3-4):152-62. PubMed ID: 22532451
[TBL] [Abstract][Full Text] [Related]
17. DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma.
Lee KF; Tsai MM; Tsai CY; Huang CG; Ou YH; Hsieh CC; Hsieh HL; Wang CS; Lin KH
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766266
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance of a Novel Multiplex Immunoassay in Colorectal Cancer.
Dressen K; Hermann N; Manekeller S; Walgenbach-Bruenagel G; Schildberg FA; Hettwer K; Uhlig S; Kalff JC; Hartmann G; Holdenrieder S
Anticancer Res; 2017 May; 37(5):2477-2486. PubMed ID: 28476816
[TBL] [Abstract][Full Text] [Related]
19. Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers.
Dou Y; Lv Y; Zhou X; He L; Liu L; Li P; Sun Y; Wang M; Gao M; Wang C
Onco Targets Ther; 2018; 11():1743-1756. PubMed ID: 29636621
[TBL] [Abstract][Full Text] [Related]
20. The Importance of Determining Preoperative Serum Concentration of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Assessing the Progression of Colorectal Cancer.
Halilovic E; Rasic I; Sofic A; Mujic A; Rovcanin A; Hodzic E; Kulovic E
Med Arch; 2020 Oct; 74(5):346-349. PubMed ID: 33424087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
